Sunday, September 14, 2025 9/14/2025

Establishing Multimodal Brain Biomarkers Using Data-driven Analytics for Treatment Selection in Depression

Award Number: R01MH129694
ORGANIZATION: NATIONAL INSTITUTE OF MENTAL HEALTH
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 05/01/2023
PERIOD OF PERFORMANCE END DATE: 02/29/2028

Group Awards By:

View Award Description

Establishing Multimodal Brain Biomarkers Using Data-driven Analytics for Treatment Selection in Depression - Project Abstract Major depression is the leading cause of ill health and disability worldwide according to the World Health Organization. Although significant progress has been made in understanding the disease and developing treatments, antidepressants, as the treatment mainstay, are effective for only about 50% of patients, in part due to the neurobiological and clinical heterogeneity in depression. Developing advanced data-driven techniques by leveraging machine learning with large-scale multimodal neuroimaging data from randomized clinical trials provides us a unique opportunity to explore brain biomarkers to identify treatment-predictive neurobiological phenotypes. Establishing such biomarkers is crucial for reducing the need for multiple drug trials and expediting remission by sharpening the search for treatment targets. However, integrative analysis of multimodal data for identifying biomarkers and differentiating individual responses to treatment in depression remains highly challenging and underexplored. In this proposal, we will develop new data-driven analytical tools to quantify multimodal moderators and signatures jointly from pre-treatment functional magnetic resonance imaging (fMRI) and electroencephalography (EEG) data for the prediction of treatment response to antidepressant medication. In Aim 1, we will identify multimodal moderators of treatment effect using data from the Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care (EMBARC) trial. A canonical correlation analysis-based data-driven model will be designed to extract combined features that fuse together complementary information from both fMRI and EEG modalities. Intent-to-treat prediction linear mixed models will be used to probe multimodal moderators of antidepressant sertraline versus placebo treatment response. In Aim 2, we will build a supervised latent space model that unifies the feature fusion and predictive modeling and apply it to quantify multimodal brain signatures that can predict individual treatment responses to sertraline versus placebo medication. In Aim 3, we will recruit 50 depressed patients as an independent cohort undergoing sertraline treatment to optimize and validate the identified multimodal biomarkers. Both fMRI and EEG will be collected at baseline followed by treatment with the antidepressant medication sertraline (in a manner paralleling EMBARC procedures) and clinical assessment of outcomes. We will release the developed software tools and collected data to be publicly available to the research community to facilitate multimodal neuroimaging studies in other mental disorders.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $710,050 )
2025	2025	LEHIGH UNIVERSITY	526 BRODHEAD AVE	BETHLEHEM	PA	18015	NORTHAMPTON	USA	Mental Health Research Grants	002	3	8/18/2025	NON-COMPETING CONTINUATION	-$666,196
2025	2025	LEHIGH UNIVERSITY	526 BRODHEAD AVE	BETHLEHEM	PA	18015	NORTHAMPTON	USA	Mental Health Research Grants	000	3	3/11/2025	NON-COMPETING CONTINUATION	$566,267
2025	2025	THE LELAND STANFORD JUNIOR UNIVERSITY	450 JANE STANFORD WAY	STANFORD	CA	94305	SANTA CLARA	USA	Mental Health Research Grants	003	4	8/18/2025	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$710,049
2025	2025	LEHIGH UNIVERSITY	526 BRODHEAD AVE	BETHLEHEM	PA	18015	NORTHAMPTON	USA	Mental Health Research Grants	001	3	7/2/2025	NON-COMPETING CONTINUATION	$99,930
														Subtotal = $710,050

Issue Date FY: 2024 ( Subtotal = $670,872 )
2024	2024	LEHIGH UNIVERSITY	526 BRODHEAD AVE	BETHLEHEM	PA	18015	NORTHAMPTON	USA	Mental Health Research Grants	001	2	5/13/2024	NON-COMPETING CONTINUATION	$67,086
2024	2024	LEHIGH UNIVERSITY	526 BRODHEAD AVE	BETHLEHEM	PA	18015	NORTHAMPTON	USA	Mental Health Research Grants	000	2	2/22/2024	NON-COMPETING CONTINUATION	$603,786
														Subtotal = $670,872

Issue Date FY: 2023 ( Subtotal = $720,800 )
2023	2023	LEHIGH UNIVERSITY	526 BRODHEAD AVE	BETHLEHEM	PA	18015	NORTHAMPTON	USA	Mental Health Research Grants	000	1	4/27/2023	NEW	$720,800
														Subtotal = $720,800

Grand Total All Awards = $2,101,722

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Establishing Multimodal Brain Biomarkers Using Data-driven Analytics for Treatment Selection in Depression

Award Number: R01MH129694

ORGANIZATION: NATIONAL INSTITUTE OF MENTAL HEALTH

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 05/01/2023

PERIOD OF PERFORMANCE END DATE: 02/29/2028

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer